Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.00
Ask: 18.00
Change: -0.25 (-1.41%)
Spread: 1.00 (5.882%)
Open: 17.75
High: 17.75
Low: 17.50
Prev. Close: 17.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Victorian Plumbing profit up; Duke revenue dips

Wed, 22nd Nov 2023 14:15

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Tremor International Ltd - Israel-headquartered company offering an end-to-end technology advertising platform - Says revenue in the third quarter of the year grew 13% to USD80.1 million from USD70.9 million the year prior. Nevertheless, swings to pretax loss to USD4.04 million from a USD3.50 million profit the year before. Operating costs increase 33% to USD69.8 million from USD52.7 million. Looking ahead, it says ongoing uncertainty will limit customer spending through to the rest of 2023. Expects approximately between USD80 million and USD85 million in adjusted earnings before interest, tax, depreciation and amortisation for the full year.

----------

Rockwood Strategic PLC - London-based investor in smaller UK public companies, formerly known as Rockwood Realisation PLC - Says net asset value per share at September 30 was 1,851.62 pence, down from 1,959.56p at March 31. NAV total return in six months to September 30 was negative 5.5%, compared to a decline in the FTSE AIM All Share Index of negative 10.3%. Chair Noel Lamb says: "The first half of our financial year has been a challenging one for UK small company stock market investors, with sustained outflows from the asset class amidst negative sentiment as interest rates continued to rise against a subdued economic backdrop. For those with sensible time horizons, these are typically the conditions for positive future medium-term returns, not least due to the heavily depressed valuations of small company shares relative to history. Private equity and trade buyers are clearly recognising the opportunities created by this environment, with the drumbeat of takeovers within Rockwood's portfolio continuing throughout 2023. We are delighted that during the period, the long-standing share price discount to Net Asset Value was closed, and we were able to grow our shareholder base."

----------

Victorian Plumbing Group PLC - Lancashire, England-based bathroom retailer - Says pretax profit in the year ended September 30 grows 32% GBP15.6 million from GBP11.8 million a year prior as revenue rises 5.8% to GBP285.1 million from GBP269.4 million the year before. Proposes a final dividend of 0.95 pence per share, bringing the total dividend to 1.40p per share, up 73% from 1.10p the year before. Looking ahead, it says it is "confident" in future growth prospects. Chief Executive Officer Mark Radcliffe says: "As a highly cash generative business with a strong balance sheet, we continue to invest in the business - across people, technology and infrastructure. Our new purpose-built 544,000 square feet distribution centre, once operational, will enable further growth in the core bathroom category, as well as unlocking further strategic category expansion. We are confident that Victorian Plumbing's profitable growth strategy will continue to deliver long-term value to all stakeholders."

----------

Duke Royalty Ltd - Guernsey-based provider of royalty finance to companies in UK and Europe - Says total revenue for the half year ended September 30 falls 66% to GBP10.4 million from GBP31.0 million the year before. Recurring cash revenue totalled GBP12.2 million, up 17% from GBP10.4 million in the first half of financial 2023. Pretax profit stoops by 81% to GBP3.8 million from GBP20.4 million a year prior. Maintains its quarterly dividend of 0.70 pence per share. Looking ahead, says it is "well-positioned" for growth. Chair Nigel Birrell comments: "During the interim period, Duke was able to post its twelfth consecutive quarter of increasing recurring cash revenue, which was a fantastic achievement for the company. In line with this strong financial performance, the company also maintained its quarterly dividend of 0.70p per share. Investors can be reassured that the dividend payout remains well covered by operating cashflow, with the attractive yield representing a pillar of Duke's ongoing business model and its overall financial discipline."

----------

Atlantic Lithium Ltd - Sydney-based lithium exploration and development company, with assets in Ghana and Ivory Coast - Says beginning of construction of Ewoyaa lithium project in Ghana will begin in late 2024, with initial production expected in early 2025. CEO Keith Muller says: "Being now within only two years from initial production, the company continues to actively recruit experienced individuals to bolster the expertise of the leadership team ahead of mine build and operation, while also ensuring a successful transition to becoming a lithium producer. We are delighted to welcome three general managers to the team, each bringing significant expertise from across the mining sector. We expect to continue to grow our teams, both in Ghana and in Australia, as we near construction."

----------

OptiBiotix Health PLC - York, England-based life sciences company - Wins grant from the University of Reading for research of its prebiotic and mineral complex, WellBiome. Says the study will assess Well Biome's impact on the gut microbiome. CEO Stephen O'Hara says: "The award of this grant to investigate WellBiome's impact on the gut microbiome throughout its length is another step in OptiBiotix's strategy of developing science based functional ingredients which modify the human microbiome to improve health. Consumer understanding and interest in the microbiome and the role of gut health in general health and wellbeing is growing rapidly, particularly in the US, and this is creating a market opportunity that is large and expanding."

----------

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
19 Jan 2021 16:30

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

Read more
11 Jan 2021 17:29

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

Read more
5 Jan 2021 17:55

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

Read more
9 Dec 2020 16:08

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

Read more
18 Nov 2020 14:53

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

Read more
18 Nov 2020 12:23

OptiBiotix grants LPLDL licence to Canada's Genuine Health

(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has granted a non-exclusive licence for 'LPLDL' to Genuine Health, for a cardiovascular health product in Canada and the United States.

Read more
12 Oct 2020 14:34

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

Read more
12 Oct 2020 14:00

OptiBiotix products launch into retail in Australia, New Zealand

(Sharecast News) - Life sciences company OptiBiotix Health announced the launch of meal replacement shakes and bars containing its 'OptiBiome' proprietary weight management technology under the 'Optislim' brand with the Woolworths and Chemist Warehouse retailers, and online, in Australia and New Zealand.

Read more
8 Oct 2020 21:16

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

Read more
6 Oct 2020 14:36

IN BRIEF: OptiBiotix's ProBiotix Inks Singaporean Deal For CholBiomeX3

IN BRIEF: OptiBiotix's ProBiotix Inks Singaporean Deal For CholBiomeX3

Read more
2 Oct 2020 11:13

OptiBiotix Notes FDA Approval For Investigation Into Partner's New Drug

OptiBiotix Notes FDA Approval For Investigation Into Partner's New Drug

Read more
2 Oct 2020 10:17

OptiBiotix shares rise as partner Seed gets FDA approval

(Sharecast News) - Life sciences company OptiBiotix Health announced on Friday that one of its partners, Seed Health, has received US Food and Drug Administration authorisation for an investigational new drug (IND) application for 'DS-01'.

Read more
24 Sep 2020 12:25

OptiBiotix revenue improves fivefold in first half

(Sharecast News) - Life sciences company OptiBiotix Health reported first-half revenue growth to £0.74m in its first half on Thursday, which was a five times increase in revenues from the first half of 2019.

Read more
24 Sep 2020 12:04

IN BRIEF: OptiBiotix Pretax Loss Narrows, Prepares For Dual Listing

IN BRIEF: OptiBiotix Pretax Loss Narrows, Prepares For Dual Listing

Read more
22 Sep 2020 15:04

IN BRIEF: OptiBiotix Inks SlimBiome License Deal With HiLife Vitamins

IN BRIEF: OptiBiotix Inks SlimBiome License Deal With HiLife Vitamins

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.